Cargando…

Non-Coding RNAs in the Therapeutic Landscape of Pathological Cardiac Hypertrophy

Cardiovascular diseases are a major health problem, and long-term survival for people diagnosed with heart failure is, still, unrealistic. Pathological cardiac hypertrophy largely contributes to morbidity and mortality, as effective therapeutic approaches are lacking. Non-coding RNAs (ncRNAs) arise...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silva, Joana, da Costa Martins, Paula A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180404/ https://www.ncbi.nlm.nih.gov/pubmed/35681500 http://dx.doi.org/10.3390/cells11111805

Ejemplares similares

Non‐coding RNAs in cardiac hypertrophy
por: Ottaviani, Lara, et al.
Publicado: (2017)

Non-coding RNAs in Cardiac Intercellular Communication
por: Videira, Raquel Figuinha, et al.
Publicado: (2020)

The Emerging Role of MicroRNAs and Other Non-Coding RNAs in Cancer Cachexia
por: Santos, Joana M. O., et al.
Publicado: (2020)

Non-Coding RNAs as Blood-Based Biomarkers in Cardiovascular Disease
por: Videira, Raquel Figuinha, et al.
Publicado: (2020)

MicroRNAs in Cardiac Hypertrophy
por: Wehbe, Nadine, et al.
Publicado: (2019)

The Role and Molecular Mechanism of Non-Coding RNAs in Pathological Cardiac Remodeling
por: Gao, Jinning, et al.
Publicado: (2017)

Non-coding RNA-linked epigenetic regulation in cardiac hypertrophy
por: Dong, Yanhan, et al.
Publicado: (2018)

Whole transcriptome microarrays identify long non-coding RNAs associated with cardiac hypertrophy
por: Zhang, Lu, et al.
Publicado: (2015)

Targeting Autophagy Using Long Non-Coding RNAs (LncRNAs): New Landscapes in the Arena of Cancer Therapeutics
por: Kumar, Aviral, et al.
Publicado: (2023)

The Multiple Myeloma Landscape: Epigenetics and Non-Coding RNAs
por: Coira, Isabel F., et al.
Publicado: (2022)

Circular RNAs in the regulation of cardiac hypertrophy
por: Wu, Siyi, et al.
Publicado: (2021)

Functions of Autophagy in Pathological Cardiac Hypertrophy
por: Li, Zhenhua, et al.
Publicado: (2015)

Non-coding RNAs in cardiac regeneration
por: Tao, Lichan, et al.
Publicado: (2015)

Non‐coding RNAs in cardiomyocyte proliferation and cardiac regeneration: Dissecting their therapeutic values
por: Dong, Xiaoxuan, et al.
Publicado: (2021)

Noncoding RNAs in Cardiac Hypertrophy and Heart Failure
por: Lu, Peilei, et al.
Publicado: (2022)

Cardiac Hypertrophy
por: DaCosta,
Publicado: (1891)

Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophy
por: Viereck, Janika, et al.
Publicado: (2020)

Long Non-Coding RNAs in Gliomas: From Molecular Pathology to Diagnostic Biomarkers and Therapeutic Targets
por: Vecera, Marek, et al.
Publicado: (2018)

The landscape of non-coding RNAs in the immunopathogenesis of Endometriosis
por: Abbaszadeh, Mohammad, et al.
Publicado: (2023)

Overview of MicroRNAs in Cardiac Hypertrophy, Fibrosis, and Apoptosis
por: Wang, Juan, et al.
Publicado: (2016)

Identification and analysis of a key long non‐coding RNAs (lncRNAs)‐associated module reveal functional lncRNAs in cardiac hypertrophy
por: Zhang, Jian, et al.
Publicado: (2017)

Non-Coding RNAs in Cell-to-Cell Communication: Exploiting Physiological Mechanisms as Therapeutic Targets in Cardiovascular Pathologies
por: Laura Francés, Javier, et al.
Publicado: (2023)

Exploring the landscape of tools and resources for the analysis of long non-coding RNAs
por: Ballarino, Monica, et al.
Publicado: (2023)

Exosomal Non-Coding RNAs: Diagnostic, Prognostic and Therapeutic Applications in Cancer
por: Bullock, Marc D., et al.
Publicado: (2015)

Long non-coding RNAs regulation of therapeutic resistance
por: Tsang, Susan, et al.
Publicado: (2019)

Regulation of microvascularization in heart failure - an endothelial cell, non-coding RNAs and exosome liaison
por: Juni, Rio P., et al.
Publicado: (2017)

Vault RNAs (vtRNAs): Rediscovered non-coding RNAs with diverse physiological and pathological activities
por: Aghajani Mir, Mahsa
Publicado: (2023)

A long non-coding RNA protects the heart from pathological hypertrophy
por: Han, Pei, et al.
Publicado: (2014)

AMD Genomics: Non-Coding RNAs as Biomarkers and Therapeutic Targets
por: Zhang, Charles, et al.
Publicado: (2022)

VCP represses pathological cardiac hypertrophy
por: Zhou, Ning, et al.
Publicado: (2017)

Long Non-Coding RNA-ROR Mediates the Reprogramming in Cardiac Hypertrophy
por: Jiang, Feng, et al.
Publicado: (2016)

The role of long non-coding RNAs in cardiac development and disease
por: García-Padilla, Carlos, et al.
Publicado: (2018)

Research Progress of Exosomal Non-Coding RNAs in Cardiac Remodeling
por: Liu, Yang, et al.
Publicado: (2023)

Non-coding RNAs in Cardiac Regeneration
por: Yuan, Ting, et al.
Publicado: (2021)

Identification of circular RNAs in cardiac hypertrophy and cardiac fibrosis
por: Chen, Yan, et al.
Publicado: (2022)

Diagnostic and Therapeutic Implications of Long Non-Coding RNAs in Leukemia
por: Gasic, Vladimir, et al.
Publicado: (2022)

Non-coding RNAs in depression: Promising diagnostic and therapeutic biomarkers
por: Shi, Yachen, et al.
Publicado: (2021)

Non-coding RNAs: key regulators of reprogramming, pluripotency, and cardiac cell specification with therapeutic perspective for heart regeneration
por: Hunkler, Hannah J, et al.
Publicado: (2021)

LncRNAs in cardiac hypertrophy: From basic science to clinical application
por: Liu, Lei, et al.
Publicado: (2020)

The Emerging Landscape of Long Non-Coding RNAs in Wilms Tumor
por: Liu, Qiang
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0atjdrrv9qkdiaof6rbunt55bj